NCT05992909 Prophylactic Lymphovenous Bypass Procedure Following Inguinal Lymphadenectomy or Pelvic Lymphadenectomy: A Prospective Observational Study
| NCT ID | NCT05992909 |
| Status | Recruiting |
| Phase | — |
| Sponsor | M.D. Anderson Cancer Center |
| Condition | Lymphadenectomy |
| Study Type | OBSERVATIONAL |
| Enrollment | 20 participants |
| Start Date | 2023-08-02 |
| Primary Completion | 2027-08-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 20 participants in total. It began in 2023-08-02 with a primary completion date of 2027-08-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
To learn if LBP can help to prevent lymphedema when it is performed at the time of surgery rather than after a patient has already developed the disease.
Eligibility Criteria
Eligibility Criteria: 1. Patients greater than or equal to 18 years of age. 2. Patients willing to participate. 3. Patients able to complete informed consent. 4. Patients undergoing ILND and/or PLND. Exclusion Criteria: 1. Patients taking anticoagulants within 7 days prior to surgery. 2. Patients that are known to be pregnant at the time of surgery. 3. Patients are available for follow-up less than 18 months or do not undergo measurements within the scheduled period. 4. Patients with BMI greater than 50.0.
Contact & Investigator
Ashleigh Francis, MD
PRINCIPAL INVESTIGATOR
M.D. Anderson Cancer Center
Frequently Asked Questions
Who can join the NCT05992909 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Lymphadenectomy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05992909 currently recruiting?
Yes, NCT05992909 is actively recruiting participants. Contact the research team at amfrancis@mdanderson.org for enrollment information.
Where is the NCT05992909 trial being conducted?
This trial is being conducted at Houston, United States.
Who is sponsoring the NCT05992909 clinical trial?
NCT05992909 is sponsored by M.D. Anderson Cancer Center. The principal investigator is Ashleigh Francis, MD at M.D. Anderson Cancer Center. The trial plans to enroll 20 participants.